567 related articles for article (PubMed ID: 11597138)
1. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
[TBL] [Abstract][Full Text] [Related]
2. Defining a common region of deletion at 13q21 in human cancers.
Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT
Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524
[TBL] [Abstract][Full Text] [Related]
3. Identification of a I-cM region of common deletion on 13q14 associated with human prostate cancer.
Ueda T; Emi M; Suzuki H; Komiya A; Akakura K; Ichikawa T; Watanabe M; Shiraishi T; Masai M; Igarashi T; Ito H
Genes Chromosomes Cancer; 1999 Mar; 24(3):183-90. PubMed ID: 10451697
[TBL] [Abstract][Full Text] [Related]
4. Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer.
Hyytinen ER; Frierson HF; Boyd JC; Chung LW; Dong JT
Genes Chromosomes Cancer; 1999 Jun; 25(2):108-14. PubMed ID: 10337994
[TBL] [Abstract][Full Text] [Related]
5. Deletion at 13q21 is associated with aggressive prostate cancers.
Dong JT; Chen C; Stultz BG; Isaacs JT; Frierson HF
Cancer Res; 2000 Jul; 60(14):3880-3. PubMed ID: 10919663
[TBL] [Abstract][Full Text] [Related]
6. Defining the region(s) of deletion at 6q16-q22 in human prostate cancer.
Hyytinen ER; Saadut R; Chen C; Paull L; Koivisto PA; Vessella RL; Frierson HF; Dong JT
Genes Chromosomes Cancer; 2002 Jul; 34(3):306-12. PubMed ID: 12007191
[TBL] [Abstract][Full Text] [Related]
7. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
[TBL] [Abstract][Full Text] [Related]
8. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
Lerman MI; Minna JD
Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
[TBL] [Abstract][Full Text] [Related]
9. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.
Bova GS; Carter BS; Bussemakers MJ; Emi M; Fujiwara Y; Kyprianou N; Jacobs SC; Robinson JC; Epstein JI; Walsh PC
Cancer Res; 1993 Sep; 53(17):3869-73. PubMed ID: 7689419
[TBL] [Abstract][Full Text] [Related]
10. A 700-kb physical and transcription map of the cervical cancer tumor suppressor gene locus on chromosome 11q13.
Zainabadi K; Benyamini P; Chakrabarti R; Veena MS; Chandrasekharappa SC; Gatti RA; Srivatsan ES
Genomics; 2005 Jun; 85(6):704-14. PubMed ID: 15885497
[TBL] [Abstract][Full Text] [Related]
11. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3.
Yin Z; Spitz MR; Babaian RJ; Strom SS; Troncoso P; Kagan J
Oncogene; 1999 Dec; 18(52):7576-83. PubMed ID: 10602517
[TBL] [Abstract][Full Text] [Related]
12. Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
Stilgenbauer S; Nickolenko J; Wilhelm J; Wolf S; Weitz S; Döhner K; Boehm T; Döhner H; Lichter P
Oncogene; 1998 Apr; 16(14):1891-7. PubMed ID: 9583687
[TBL] [Abstract][Full Text] [Related]
13. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
[TBL] [Abstract][Full Text] [Related]
14. Distinct regions of allelic loss on 13q in prostate cancer.
Cooney KA; Wetzel JC; Merajver SD; Macoska JA; Singleton TP; Wojno KJ
Cancer Res; 1996 Mar; 56(5):1142-5. PubMed ID: 8640774
[TBL] [Abstract][Full Text] [Related]
15. The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis.
Toomes C; Jackson A; Maguire K; Wood J; Gollin S; Ishwad C; Paterson I; Prime S; Parkinson K; Bell S; Woods G; Markham A; Oliver R; Woodward R; Sloan P; Dixon M; Read A; Thakker N
Genes Chromosomes Cancer; 2003 Jun; 37(2):132-40. PubMed ID: 12696061
[TBL] [Abstract][Full Text] [Related]
16. Localization of potential tumor suppressor loci to a < 2 Mb region on chromosome 17q in human prostate cancer.
Gao X; Zacharek A; Grignon DJ; Sakr W; Powell IJ; Porter AT; Honn KV
Oncogene; 1995 Oct; 11(7):1241-7. PubMed ID: 7478543
[TBL] [Abstract][Full Text] [Related]
17. Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion.
Latil A; Chêne L; Mangin P; Fournier G; Berthon P; Cussenot O
Prostate; 2003 Sep; 57(1):39-50. PubMed ID: 12886522
[TBL] [Abstract][Full Text] [Related]
18. Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia.
Kalachikov S; Migliazza A; Cayanis E; Fracchiolla NS; Bonaldo MF; Lawton L; Jelenc P; Ye X; Qu X; Chien M; Hauptschein R; Gaidano G; Vitolo U; Saglio G; Resegotti L; Brodjansky V; Yankovsky N; Zhang P; Soares MB; Russo J; Edelman IS; Efstratiadis A; Dalla-Favera R; Fischer SG
Genomics; 1997 Jun; 42(3):369-77. PubMed ID: 9205107
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence in situ hybridization deletion mapping at 4p16.3 in bladder cancer cell lines refines the localisation of the critical interval to 30 kb.
Bell SM; Zuo J; Myers RM; Knowles MA
Genes Chromosomes Cancer; 1996 Oct; 17(2):108-17. PubMed ID: 8913728
[TBL] [Abstract][Full Text] [Related]
20. Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer.
Srivatsan ES; Chakrabarti R; Zainabadi K; Pack SD; Benyamini P; Mendonca MS; Yang PK; Kang K; Motamedi D; Sawicki MP; Zhuang Z; Jesudasan RA; Bengtsson U; Sun C; Roe BA; Stanbridge EJ; Wilczynski SP; Redpath JL
Oncogene; 2002 Aug; 21(36):5631-42. PubMed ID: 12165862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
